Nexalin Technology (NXL) Return on Sales (2021 - 2026)

Nexalin Technology's Return on Sales history runs 6 years deep, the most recent figure standing at 1.4% for Q1 2026.

• In Q1 2026, Return on Sales fell 92.0% year-over-year to 1.4%; the TTM figure through Mar 2026 stood at 0.3% (up 35.0% YoY), while the FY2025 annual figure was 0.27%, up 18.0% from the prior year.
• Return on Sales was 1.4% for Q1 2026 at Nexalin Technology, down from 0.14% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q3 2022 to a low of 1.4% in Q1 2026.
• Historically, Return on Sales has averaged 0.46% across 5 years, with a median of 0.24% in 2023.
• The sharpest annual moves came in 2023 and 2025: Return on Sales slumped 95 bps in 2023, then jumped 90 bps in 2025.
• A 5-year view of Return on Sales shows it stood at 0.19% in 2022, then plunged by 99 bps to 0.38% in 2023, then slumped by 174 bps to 1.04% in 2024, then jumped by 87 bps to 0.14% in 2025, then sank by 914 bps to 1.4% in 2026.
• The last three Return on Sales figures came in at 1.4% (Q1 2026), 0.14% (Q4 2025), and 1.25% (Q3 2025), per Business Quant data.